Sildenafil and Bosentan Plasma Concentrations in a Human Immunodeficiency Virus- Infected Patient with Pulmonary Arterial Hypertension Treated with Ritonavir-Boosted Protease Inhibitor

Sildenafil and bosentan are increasingly used for the treatment of pulmonary arterial hypertension (PAH) in HIV-infected patients. However, concerns exist about pharmacokinetic interactions among sildenafil, bosentan and antiretroviral drugs, including protease inhibitors (PI). We describe here the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinello, Pierangelo, Cicalini, Stefania, Pichini, Simona, Pacifici, Roberta, Tempestilli, Massimo, Cicini, Maria P., Pucillo, Leopoldo P., Petrosillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387373/
https://www.ncbi.nlm.nih.gov/pubmed/25874072
http://dx.doi.org/10.4081/idr.2015.5822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387373/
https://www.ncbi.nlm.nih.gov/pubmed/25874072
http://dx.doi.org/10.4081/idr.2015.5822

Ejemplares similares